Search by Drug Name or NDC

    NDC 62559-0980-15 Clobetasol Propionate (Emmolient) 0.5 mg/g Details

    Clobetasol Propionate (Emmolient) 0.5 mg/g

    Clobetasol Propionate (Emmolient) is a TOPICAL CREAM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ANI Pharmaceuticals, Inc.. The primary component is CLOBETASOL PROPIONATE.

    Product Information

    NDC 62559-0980
    Product ID 62559-980_3afb8221-d476-4c1b-949f-080c77e3a2a2
    Associated GPIs 90550025153705
    GCN Sequence Number 021986
    GCN Sequence Number Description clobetasol propionate/emoll CREAM (G) 0.05 % TOPICAL
    HIC3 Q5P
    HIC3 Description TOPICAL ANTI-INFLAMMATORY STEROIDAL
    GCN 34141
    HICL Sequence Number 009061
    HICL Sequence Number Description CLOBETASOL PROPIONATE/EMOLLIENT BASE
    Brand/Generic Generic
    Proprietary Name Clobetasol Propionate (Emmolient)
    Proprietary Name Suffix n/a
    Non-Proprietary Name Clobetasol Propionate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CREAM
    Route TOPICAL
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/g
    Substance Name CLOBETASOL PROPIONATE
    Labeler Name ANI Pharmaceuticals, Inc.
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA075733
    Listing Certified Through n/a

    Package

    NDC 62559-0980-15 (62559098015)

    NDC Package Code 62559-980-15
    Billing NDC 62559098015
    Package 1 TUBE in 1 CARTON (62559-980-15) / 15 g in 1 TUBE
    Marketing Start Date 2021-03-12
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 1.13543
    Pricing Unit GM
    Effective Date 2022-11-23
    NDC Description CLOBETASOL EMOLLIENT 0.05% CRM
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis